Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
After eight months of work and several sea trials, the French aircraft carrier Charles de Gaulle has begun a six-week operation in the Mediterranean, ...
Read More
A group of experts have come up with more than 150 recommendations for how Nice can deal with the increasing effects of climate change....
Read More
Some communes in the Alpes-Maritimes will be plunged into darkness this Monday evening. For the third year running to mark Earth Day, mayors in the Al...
Read More
Gendarmes in the Var have appealed for information after a 34-year-old man went missing in Cavalaire-sur-Mer....
Read More
A man from Nice used a stolen bank card to make purchases in Monaco, spending over €1,700 in various shops, mostly on airpods that he planned to resel...
Read More
